Natasha M Archer (Natasha Archer)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Sickle Cell Disease

Aortic Dissection

Extracorporeal Membrane Oxygenation

Neuropathic Pain

Top Venues

Pediatric blood & cancer

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey G Edwards, Adam Paul Yan, Ramy Yim, Mo Oni, Matthew M Heeney, Dave Johnson, Chris I Wong, Maya Ilowite, Natasha M Archer
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project. Pediatric blood & cancer 71 (8) (2024)
Jeffrey G Edwards, Adam Paul Yan, Ramy Yim, Mo Oni, Matthew M Heeney, Dave Johnson, Chris I Wong, Maya Ilowite, Natasha M Archer
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project. Pediatric blood & cancer (2024)
Jeffrey G Edwards, Adam Paul Yan, Ramy Yim, Mo Oni, Matthew M Heeney, Dave Johnson, Chris I Wong, Maya Ilowite, Natasha M Archer
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project. Pediatric blood & cancer 71 (8) (2024)
Natasha M Archer
Diversity, equity, and inclusion: Moving from ambition to action. Pediatric blood & cancer (2023)
Morohuntodun O Oni, Natasha M Archer
Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease? American journal of hematology 98 (4) (2023)
Emily M Harris, Carolina Donado, Natasha M Archer
Reply to: Comment on: Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease. Pediatric blood & cancer (2023)
Morohuntodun O Oni, Natasha M Archer
Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease? American journal of hematology 98 (4) (2023)
Morohuntodun O Oni, Natasha M Archer
Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease? American journal of hematology 98 (4) (2023)
Natasha M Archer
Diversity, equity, and inclusion: Moving from ambition to action. Pediatric blood & cancer 70 (4) (2023)
Natasha M Archer
Diversity, equity, and inclusion: Moving from ambition to action. Pediatric blood & cancer 70 (4) (2023)
Natasha M Archer, Bénédicte Gnangnon, Mahmoud Mikdar, Marioara F Ciuculescu, Nicole Petersen, Steven J Staffa, Manoj T Duraisingh
F-cells promote Plasmodium falciparum proliferation in sickle cell disease. American journal of hematology (2023)
Morohuntodun O Oni, Natasha M Archer
Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease? American journal of hematology (2023)
Morohuntodun Oni, Natasha M Archer
Intranasal fentanyl works - why aren't we using it more to treat acute pain in sickle cell disease? American journal of hematology (2023)
Jeffrey G Edwards, Natasha M Archer
A seat at the table: A perspective on participation of Black individuals in clinical trials. Pediatric blood & cancer 69 (5) (2022)
Natasha M Archer, Baba Inusa, Julie Makani, Siana Nkya, Léon Tshilolo, Venee N Tubman, Patrick T McGann, Emmanuela Eusebio Ambrose, Natalie Henrich, Jonathan Spector, Kwaku Ohene-Frempong
Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries. BMJ open 12 (3) (2022)
Natasha M Archer, Geoffrey Pasvol, Iain Wilson, Manoj T Duraisingh
Does fetal hemoglobin inhibit the malarial parasite Plasmodium falciparum? American journal of hematology 97 (9) (2022)
Narcisse Elenga, Simon Kayemba-Kay's, Mathieu Nacher, Natasha M Archer
A call to start hydroxyurea by 6 months of age and before the advent of sickle cell disease complications. Pediatric blood & cancer (2021)
Tolulope O Rosanwo, Leslie S Kean, Natasha M Archer
End the pain: Start with antiracism. American journal of hematology 96 (1) (2020)